Literature DB >> 35132592

The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2.

Emily Clayton1, Mohammed A Rohaim1, Mahmoud Bayoumi1, Muhammad Munir2.   

Abstract

INTRODUCTION: Coronaviruses (CoVs) are large, enveloped and positive-sense RNA viruses which are responsible for a range of upper respiratory and digestive tract infections. Interest in coronaviruses has recently escalated due to the identification of a newly emerged coronavirus named severe acute respiratory syndrome 2 (SARS-CoV-2), which is the causative agent of the COVID-19 pandemic. In this chapter, we summarise molecular virological features of coronaviruses and understand their molecular mechanisms of replication in guiding the control of the global COVID-19 pandemic.
METHODS: We applied a holistic and comparative approach to assess the current understanding of coronavirus molecular virology and identify research gaps among different human coronaviruses.
RESULTS: Coronaviruses can utilise unique strategies that aid in their pathogenicity, replication and survival in multiple hosts. Replication of coronaviruses involves novel mechanisms such as ribosomal frameshifting and the synthesis of both genomic and sub-genomic RNAs. We summarised the key components in coronavirus molecular biology and molecular determinants of pathogenesis. Focusing largely on SARS-CoV-2 due to its current importance, this review explores the virology of recently emerged coronaviruses to gain an in-depth understanding of these infectious diseases.
CONCLUSIONS: The presented information provides fundamental bottlenecks to devise future disease control and management strategies to curtail the impact of coronaviruses in human populations.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Mesh:

Year:  2021        PMID: 35132592     DOI: 10.1007/978-3-030-85109-5_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  74 in total

Review 1.  Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic.

Authors:  Roy M Anderson; Christophe Fraser; Azra C Ghani; Christl A Donnelly; Steven Riley; Neil M Ferguson; Gabriel M Leung; T H Lam; Anthony J Hedley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-07-29       Impact factor: 6.237

2.  Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation.

Authors:  Koichi Araki; Shivaprakash Gangappa; Dirck L Dillehay; Barry T Rouse; Christian P Larsen; Rafi Ahmed
Journal:  J Exp Med       Date:  2010-10-04       Impact factor: 14.307

3.  The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex.

Authors:  Berend Jan Bosch; Ruurd van der Zee; Cornelis A M de Haan; Peter J M Rottier
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

4.  Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites.

Authors:  Sandrine Belouzard; Victor C Chu; Gary R Whittaker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-24       Impact factor: 11.205

5.  Programmed ribosomal frameshifting in decoding the SARS-CoV genome.

Authors:  Pavel V Baranov; Clark M Henderson; Christine B Anderson; Raymond F Gesteland; John F Atkins; Michael T Howard
Journal:  Virology       Date:  2005-02-20       Impact factor: 3.616

6.  Deduced sequence of the bovine coronavirus spike protein and identification of the internal proteolytic cleavage site.

Authors:  S Abraham; T E Kienzle; W Lapps; D A Brian
Journal:  Virology       Date:  1990-05       Impact factor: 3.616

7.  The 2019-new coronavirus epidemic: Evidence for virus evolution.

Authors:  Domenico Benvenuto; Marta Giovanetti; Alessandra Ciccozzi; Silvia Spoto; Silvia Angeletti; Massimo Ciccozzi
Journal:  J Med Virol       Date:  2020-02-07       Impact factor: 2.327

8.  Architecture of the SARS coronavirus prefusion spike.

Authors:  Daniel R Beniac; Anton Andonov; Elsie Grudeski; Tim F Booth
Journal:  Nat Struct Mol Biol       Date:  2006-07-16       Impact factor: 15.369

9.  The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus.

Authors:  E C Bos; W Luytjes; H V van der Meulen; H K Koerten; W J Spaan
Journal:  Virology       Date:  1996-04-01       Impact factor: 3.616

10.  Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates.

Authors:  Dae-Gyun Ahn; Jin-Kyu Choi; Deborah R Taylor; Jong-Won Oh
Journal:  Arch Virol       Date:  2012-07-13       Impact factor: 2.574

View more
  2 in total

Review 1.  Animal models for COVID-19: advances, gaps and perspectives.

Authors:  Changfa Fan; Yong Wu; Xiong Rui; Yuansong Yang; Chen Ling; Susu Liu; Shunan Liu; Youchun Wang
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

Review 2.  Development and application of ribonucleic acid therapy strategies against COVID-19.

Authors:  Lin Ning; Mujiexin Liu; Yushu Gou; Yue Yang; Bifang He; Jian Huang
Journal:  Int J Biol Sci       Date:  2022-08-01       Impact factor: 10.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.